📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Severity of BA.2 variant and vaccine effectiveness against symptomatic disease in Scotland (2022)

First Author: Kerr S

Attributed to: Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100533

PubMed Identifier: 36373099

Publication URI: http://europepmc.org/abstract/MED/36373099

Type: Journal Article/Review

Parent Publication: The Lancet Regional Health - Europe

ISSN: 2666-7762